Patients with severe psoriasis who were treated with biologic agents had reduced coronary artery disease progression, according to study results recently published in JAMA Dermatology.
Researchers in Denmark conducted a prospective, observer-blinded clinical study at a tertiary dermatology university clinic.
Read the full article at www.healio.com.
